Pre-clinical Safety and Off-Target Studies to Support Translation of AAV-Mediated RNAi Therapy for FSHD

Autor: Wallace, Lindsay M., Saad, Nizar Y., Pyne, Nettie K., Fowler, Allison M., Eidahl, Jocelyn O., Domire, Jacqueline S., Griffin, Danielle A., Herman, Adam C., Sahenk, Zarife, Rodino-Klapac, Louise R., Harper, Scott Q.

Publikováno v: In Molecular Therapy - Methods & Clinical Development 16 March 2018 8:121-130

PHYLOGENY OF LEAVENWORTHIA S-ALLELES SUGGESTS UNIDIRECTIONAL MATING SYSTEM EVOLUTION AND ENHANCED POSITIVE SELECTION FOLLOWING AN ANCIENT POPULATION BOTTLENECK

Autor: Herman, Adam C., Busch, Jeremiah W., Schoen, Daniel J.

Publikováno v: Evolution, 2012 Jun 01. 66(6), 1849-1861.

Externí odkaz: https://www.jstor.org/stable/41503486

Additional file 1 of Discovery of clinically relevant fusions in pediatric cancer

Autor: LaHaye, Stephanie, Fitch, James R., Voytovich, Kyle J., Herman, Adam C., Kelly, Benjamin J., Lammi, Grant E., Arbesfeld, Jeremy A., Wijeratne, Saranga, Franklin, Samuel J., Schieffer, Kathleen M., Bir, Natalie, McGrath, Sean D., Miller, Anthony R., Wetzel, Amy, Miller, Katherine E., Bedrosian, Tracy A., Leraas, Kristen, Varga, Elizabeth A., Lee, Kristy, Gupta, Ajay, Setty, Bhuvana, Bou��, Daniel R., Leonard, Jeffrey R., Finlay, Jonathan L., Abdelbaki, Mohamed S., Osorio, Diana S., Koo, Selene C., Koboldt, Daniel C., Wagner, Alex H., Eisfeld, Ann-Kathrin, Mr��zek, Krzysztof, Magrini, Vincent, Cottrell, Catherine E., Mardis, Elaine R., Wilson, Richard K., White, Peter

Additional file 1.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f794defc18b5c46665d6e6b50fc32acb

Secondary Evolution of a Self-Incompatibility Locus in the Brassicaceae Genus Leavenworthia

Autor: Chantha, Sier-Ching¹, Herman, Adam C.¹, Platts, Adrian E.¹, Vekemans, Xavier², Schoen, Daniel J.¹ daniel.schoen@mcgill.ca

Publikováno v: PLoS Biology. May2013, Vol. 11 Issue 5, p1-16. 16p. 5 Diagrams, 4 Graphs.

Pre-clinical Safety and Off-Target Studies to Support Translation of AAV-Mediated RNAi Therapy for FSHD.

Autor: Wallace LM; Center for Gene Therapy, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA., Saad NY; Center for Gene Therapy, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA., Pyne NK; Center for Gene Therapy, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA., Fowler AM; Center for Gene Therapy, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA., Eidahl JO; Center for Gene Therapy, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA., Domire JS; Center for Gene Therapy, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA., Griffin DA; Center for Gene Therapy, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA., Herman AC; Research Information Solutions and Innovation Infrastructure, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA., Sahenk Z; Center for Gene Therapy, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.; Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA.; Department of Neurology, The Ohio State University College of Medicine, Columbus, OH, USA., Rodino-Klapac LR; Center for Gene Therapy, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.; Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA., Harper SQ; Center for Gene Therapy, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.; Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA.

Publikováno v: Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2017 Dec 24; Vol. 8, pp. 121-130. Date of Electronic Publication: 2017 Dec 24 (Print Publication: 2018).